Aridis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Feb 14 15:33 ET
Aridis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Fund II LP(0%),Lind Global Partners II LLC(0%), etc.
Feb 13 20:06 ET
Aridis Pharmaceuticals | 8-K: Current report
Jan 16 00:00 ET
Aridis Pharmaceuticals | DEFA14A: Others
Dec 18, 2023 09:43 ET
Aridis Pharmaceuticals | 8-K: Current report
Dec 18, 2023 09:40 ET
Aridis Pharmaceuticals | DEFA14A: Others
Dec 15, 2023 17:00 ET
Aridis Pharmaceuticals: Q3 2023 Earnings Report
Nov 6, 2023 16:06 ET
Aridis Pharmaceuticals | 8-K: Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
Nov 3, 2023 17:00 ET
Aridis Pharmaceuticals | DEFA14A: Others
Nov 3, 2023 06:15 ET
Aridis Pharmaceuticals | ARS: Annual Report to Security Holders
Nov 2, 2023 17:54 ET
Aridis Pharmaceuticals | DEF 14A: Definitive information statements
Nov 2, 2023 17:51 ET
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HAMILTON JOHN F
Sep 19, 2023 16:05 ET
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Windham-Bannister Susan Richards
Sep 19, 2023 16:05 ET
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Executive Chairman Patzer Eric
Sep 19, 2023 16:05 ET
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Truong Vu
Sep 19, 2023 16:05 ET
Aridis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Jafri Hasan
Sep 19, 2023 16:05 ET
Aridis Pharmaceuticals | 10-Q: Q2 2023 Earnings Report
Sep 13, 2023 21:47 ET
Aridis Pharmaceuticals | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Sep 8, 2023 10:13 ET
Aridis Pharmaceuticals | 8-K: Current report
Sep 7, 2023 16:15 ET
Aridis Pharmaceuticals | 8-K: Current report
Aug 25, 2023 16:05 ET
No Data
No Data